About ABL Bio

Sponsor retains sole responsibility for content.

ABL Bio is biotech research company focusing on the development of therapeutic drugs for immuno-oncology & neurodegenerative diseases. 1. Lead Molecule (ABL001): Bispecific antibody targeting VEGF and Dll4 (Phase 1, Q4, 2017) 2. ADC (Antibody Drug Conjugate) projects 3. T cell engaging Bispecific antibody 4. Immunooncology MoAb 5. Immunooncology Bispecific antibody 6. Synuclein targeting antibody ...

ABL Bio is biotech research company focusing on the development of therapeutic drugs for immuno-oncology & neurodegenerative diseases. 1. Lead Molecule (ABL001): Bispecific antibody targeting VEGF and Dll4 (Phase 1, Q4, 2017) 2. ADC (Antibody Drug Conjugate) projects 3. T cell engaging Bispecific antibody 4. Immunooncology MoAb 5. Immunooncology Bispecific antibody 6. Synuclein targeting antibody with BBB-Crossing Trojan Horse Bispecific Antibody

Contact ABL Bio

Phone Number
8210-4104-0861

More About ABL Bio

Therapeutic Areas
  • Central Nervous System
  • Oncology
Technologies
  • Other
Company Type
  • Biotechnology – Therapeutics
State of Ownership
  • Private
Sponsorship Group
  • Networker